<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell Dev. Biol.</journal-id>
<journal-title>Frontiers in Cell and Developmental Biology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell Dev. Biol.</abbrev-journal-title>
<issn pub-type="epub">2296-634X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">783547</article-id>
<article-id pub-id-type="doi">10.3389/fcell.2021.783547</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cell and Developmental Biology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Deletion of <italic>Asrgl1</italic> Leads to Photoreceptor Degeneration in Mice</article-title>
<alt-title alt-title-type="left-running-head">Zhou et&#x20;al.</alt-title>
<alt-title alt-title-type="right-running-head">Asrgl1 Deletion in Mice</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Zhou</surname>
<given-names>Yu</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tian</surname>
<given-names>Wanli</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jiang</surname>
<given-names>Xiaoyan</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yang</surname>
<given-names>Huining</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jiang</surname>
<given-names>Zhilin</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/289746/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Xiao</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jiang</surname>
<given-names>Dan</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sun</surname>
<given-names>Kuanxiang</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yang</surname>
<given-names>Yeming</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Liu</surname>
<given-names>Wenjing</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1494655/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Zhu</surname>
<given-names>Xianjun</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/903728/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Sichuan Provincial Key Laboratory for Human Disease Gene Study, Department of Laboratory Medicine, Center for Medical Genetics, Sichuan Provincial People&#x2019;s Hospital, School of Medicine, University of Electronic Science and Technology of China</institution>, <addr-line>Chengdu</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Research Unit for Blindness Prevention of the Chinese Academy of Medical Sciences (2019RU026), Sichuan Academy of Medical Sciences and Sichuan Provincial People&#x2019;s Hospital</institution>, <addr-line>Chengdu</addr-line>, <country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Ophthalmology, First People&#x2019;s Hospital of Shangqiu</institution>, <addr-line>Shangqiu</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1068105/overview">Qingjiong Zhang</ext-link>, Sun Yat-sen University, China</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1227774/overview">Ruifang Sui</ext-link>, Peking Union Medical College Hospital (CAMS), China</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1052786/overview">Mallika Valapala</ext-link>, Indiana University, United&#x20;States</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1229278/overview">Wenmin Sun</ext-link>, Sun Yat-sen University, China</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Yu Zhou, <email>zhouyu422@yahoo.com</email>; Wenjing Liu, <email>nicolewjliu@163.com</email>; Xianjun Zhu, <email>xjzhu@uestc.edu.cn</email>
</corresp>
<fn fn-type="equal" id="fn1">
<label>
<sup>&#x2020;</sup>
</label>
<p>These authors have contributed equally to this&#x20;work</p>
</fn>
<fn fn-type="other">
<p>This article was submitted to Molecular and Cellular Pathology, a section of the journal Frontiers in Cell and Developmental Biology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>18</day>
<month>01</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2021</year>
</pub-date>
<volume>9</volume>
<elocation-id>783547</elocation-id>
<history>
<date date-type="received">
<day>26</day>
<month>09</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>23</day>
<month>11</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2022 Zhou, Tian, Jiang, Yang, Jiang, Li, Jiang, Sun, Yang, Liu and Zhu.</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Zhou, Tian, Jiang, Yang, Jiang, Li, Jiang, Sun, Yang, Liu and Zhu</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these&#x20;terms.</p>
</license>
</permissions>
<abstract>
<p>The asparaginase and isoaspartyl peptidase 1 (ASRGL1) is an L-asparaginase and beta-aspartyl peptidase enzyme that may be involved in the formation of L-aspartate, a neurotransmitter that can operate as an excitatory neurotransmitter in some brain regions. Although variants in <italic>ASRGL</italic>1 have been reported in retinitis pigmentosa (RP) patients, the <italic>in vivo</italic> functions and mechanisms of <italic>ASRGL</italic> in RP remains unknown due to the lack of suitable disease models. To explore the role of <italic>ASRGL</italic> in RP, we generated an <italic>Asrgl1</italic> knockout mouse model (<italic>Asrgl1</italic> KO) using the CRISPR/Cas9 technique. <italic>Asrgl1</italic> ablation in mice led to an attenuated electroretinogram (ERG) response around 8&#xa0;months. The thickness of the outer nuclei layer (ONL) started to decrease around 9&#xa0;months in <italic>Asrgl1</italic> KO mice and gradually intensified at 12 and 15&#xa0;months. Immunostaining revealed thinner inner segment (IS) and thinner outer segment (OS) as well as the progressive degeneration of rod and cone cells in <italic>Asrgl1</italic> KO mice. One hundred forty-nine transcriptional differentially expressed genes (DEGs) were found by RNA-seq in <italic>Asrgl1</italic> KO retina. These DEGs were linked to a number of biological processes that were considerably enriched, including gastrointestinal disease and organismal injury and abnormalities. By analysis of canonical pathways, glucocorticoid receptor signaling was the most significant canonical pathway altered in <italic>Asrgl1</italic> KO retina. Several molecules, including NFE2L2, IL-4, Foxp3, and Fos, were in the central nodes of the interaction network in <italic>Asrgl1</italic> KO retina. In summary, our study provided a knockout mouse model for a better understanding of the molecular mechanism for <italic>ASRGL1</italic>-related&#x20;RP.</p>
</abstract>
<kwd-group>
<kwd>retinitis pigmentosa</kwd>
<kwd>asparaginase and isoaspartyl peptidase 1</kwd>
<kwd>knockout mouse model</kwd>
<kwd>RNA-seq</kwd>
<kwd>photoreceptor degeneration</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Retinitis pigmentosa is one of the most common causes of visual impairment around the world, including symptoms such as night blindness and progressive loss of peripheral vision in the early stage, and no complete yet effective treatment exists up to date (<xref ref-type="bibr" rid="B13">Ferrari et&#x20;al., 2011</xref>). The prevalence of this disorder is approximately 1:4,000 (<xref ref-type="bibr" rid="B15">Hartong et&#x20;al., 2006</xref>). As an inherited retinal degeneration disease, it can be inherited in three ways: autosomal recessive (50%&#x2013;60%), autosomal dominant (30%&#x2013;40%), or X-linked (5%&#x2013;15%). The phenotype of non-syndromic retinitis pigmentosa (RP) in RP patients might be limited to the eye or it can be part of a syndrome that includes extraocular illnesses such hearing loss, obesity, and neurologic diseases (<xref ref-type="bibr" rid="B3">Bhatti, 2006</xref>). Over 90 genes have been associated with non-syndromic RP according to the RetNet database (<ext-link ext-link-type="uri" xlink:href="https://sph.uth.edu/retnet/">https://sph.uth.edu/retnet/</ext-link>; date last accessed Jul 30, 2021). However, only about 50%&#x2013;60% of RP cases can be explained by these mutations, and the pathological and molecular mechanisms of some of the genes remain unknown (<xref ref-type="bibr" rid="B8">Daiger et&#x20;al., 2013</xref>; <xref ref-type="bibr" rid="B16">Huang et&#x20;al., 2015</xref>).</p>
<p>Asparaginase and isoaspartyl peptidase 1 (<italic>ASRGL1</italic>) has been reported as a RP disease gene in 2016 (<xref ref-type="bibr" rid="B4">Biswas et&#x20;al., 2016</xref>). The p.G178R mutation, which causes photoreceptor degeneration and progressive vision loss, was discovered in a large five-generation pedigree with early-onset recessive retinal degeneration utilizing linkage analysis and homozygosity mapping combined with exome sequencing. <italic>ASRGL1</italic> encodes an enzyme L-asparaginase, has both L-asparaginase and beta-aspartyl peptidase activity, and may be involved in the production of L-aspartate (<xref ref-type="bibr" rid="B6">Cantor et&#x20;al., 2009</xref>). However, the pathological and molecular mechanisms of <italic>ASRGL1</italic> in causing of RP remains unknown.</p>
<p>To investigate the function of <italic>Asrgl1</italic> in the mammalian retina and explore the molecular mechanism how <italic>Asrgl1</italic> affect photoreceptors or RPE cells, we developed a novel mouse model of RP with the <italic>Asrgl1</italic> gene knockout on a C57BL/6J genetic background by CRISPR/CAS9 technology. <italic>Asrgl1</italic> ablation in mice resulted in a typical retinal degeneration phenotype with decreased electroretinogram (ERG) response; thinner outer nuclei layer (ONL), inner segment (IS), and outer segment (OS); and decreased rod and cone proteins. A high-throughput transcriptional sequencing analysis found 149 transcriptional differentially expressed genes (DEGs) between <italic>Asrgl1</italic> knockout (KO) mouse retina and the normal controls. Glucocorticoid receptor signaling was the most changed pathway and might play key roles in the pathological process of <italic>ASRGL1</italic>-related RP. Our studies provide an <italic>Asrgl1</italic> KO mouse model for improving our understanding of RP disease mechanisms.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>Materials and Methods</title>
<sec id="s2-1">
<title>Generation of <italic>Asrgl1</italic> Knockout Mice</title>
<p>The Animal Care and Use Committee of the Sichuan Provincial People&#x2019;s Hospital authorized all animal experiments, which followed the ARVO guidelines for the use of animals in ophthalmology and vision research.</p>
<p>
<italic>Asrgl1</italic> KO mice were generated by using the CRISPR/Cas9 system on C57BL/6J genetic background. The Cas9 mRNA and two single guide RNAs targeting a region upstream of exon 3 and downstream of exon 4 of <italic>Asrgl1</italic> exon 3 were microinjected into mouse zygotes (<xref ref-type="fig" rid="F1">Figure 1</xref>). gRNA1 sequence (matching reverse strand of gene) was as follows: TCT&#x200b;GTC&#x200b;GCT&#x200b;AGC&#x200b;AAC&#x200b;CAA&#x200b;CAA&#x200b;GG. gRNA2 sequence (matching forward strand of gene) was as follows: ATA&#x200b;TTG&#x200b;CTA&#x200b;GAC&#x200b;AGG&#x200b;CTT&#x200b;GGA&#x200b;GG. As confirmed by Sanger sequencing and PCR genotyping analysis, the conventional translation start site was successfully eliminated.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Generation of <italic>Asrgl1</italic> knockout (KO) mice. <bold>(A)</bold> The partial genomic sequence of <italic>Asrgl1</italic> exons was shown. The 1,388-bp genomic deletion was indicated in red. <bold>(B)</bold> Sanger sequencing of <italic>Asrgl1</italic> genome in the wild-type (WT), <italic>Asrgl1</italic>
<sup>&#x2b;/&#x2212;</sup> and <italic>Asrgl1</italic>
<sup>&#x2212;/&#x2212;</sup> mice. <bold>(C)</bold> Schematic illustration of cDNA deletion in <italic>Asrgl1</italic> KO mice. <bold>(D)</bold> Sanger sequencing of <italic>Asrgl1</italic> cDNA in WT and Asrgl1<sup>&#x2212;/&#x2212;</sup> mice. A 301-bp fragment consisting of exon 3 and 4 is deleted in <italic>Asrgl1</italic> KO allele. <bold>(E)</bold> Reverse transcription PCR analysis of <italic>Asrgl1</italic> expression in WT and <italic>Asrgl1</italic>
<sup>&#x2212;/&#x2212;</sup> mouse retinas at 3&#xa0;months of age. Gapdh was used as a loading control.</p>
</caption>
<graphic xlink:href="fcell-09-783547-g001.tif"/>
</fig>
</sec>
<sec id="s2-2">
<title>Electroretinograms in Mice</title>
<p>Mouse ERG detection was performed on an Espion Visual Electrophysiology System (Diagnosys, Lowell, MA, United&#x20;States). Briefly, female <italic>Asrgl1</italic> KO mice and female controls were dark-adapted overnight 1&#xa0;day before detection. In the next morning, before ERG, animals were anesthetized and the eyes were dilated with a drop of tropicamide and phenylephrine, as well as tetracaine (0.5%). Throughout the experiment, a heating platform was used to keep the body temperature at 37&#xb0;C. Gold wire loops were used to record dark-adapted ERGs in response to flashes with intensities ranging from 0.003 to 20&#xa0;cds/m<sup>2</sup>. After 20&#xa0;min of complete light adaptation, cone-mediated ERGs were recorded with white flashes.</p>
</sec>
<sec id="s2-3">
<title>Retinal Hematoxylin and Eosin Staining</title>
<p>The eyes with the whole retina and optic nerve were chosen for imaging by hematoxylin and eosin (H&#x26;E) staining. Female wild-type (WT) and female KO mice&#x2019;s eyes were enucleated, marked for orientation on the nasal side, fixed overnight in 1.22% glutaraldehyde and 0.8% paraformaldehyde in 0.08&#xa0;M phosphate buffer, embedded in paraffin, and cut into 5-&#x3bc;m slices. H&#x26;E staining was used on sections taken from five places around the optic nerve. The rows of photoreceptors in the outer nuclear layer were counted using H&#x26;E-stained slices. Every 200&#xa0;&#x3bc;m from the optic nerve, three measurements of the outer nuclear layer were recorded and averaged. The optic nerve was given the number 0&#xa0;mm.</p>
</sec>
<sec id="s2-4">
<title>Immunohistochemistry Analysis</title>
<p>Enucleated eyeballs were removed from female WT and female <italic>Asrgl1</italic> KO mice for immunohistochemistry, marked on the nasal side for orientation, fixed for 1&#xa0;h in 4% paraformaldehyde in 100&#xa0;mM phosphate buffer (pH 7.4), and cryoprotected in 30% sucrose. For sectioning, tissues were immersed in an optimal cutting temperature (OCT) solution and frozen on dry ice. For 30&#xa0;min, sections were blocked and permeabilized in phosphate buffer with 10% normal goat serum and 0.2% Triton X-100, then labeled with different primary antibodies overnight at 4&#xb0;C. Then, the slides were washed and incubated with secondary antibodies for 2&#xa0;h. Finally, the slides were washed and covered with coverslips. The primary antibodies used in our study were as follows: rhodopsin (1D4, cat. &#x23;MA1-722, Thermo Fisher, Waltham, MA, United&#x20;States), Na-K pump (cat. &#x23;MA3928, Thermo Fisher, Waltham, MA, United&#x20;States), opsin (red/green, cat. &#x23;AB5405, Millipore, Burlington, MA, United&#x20;States), and 594-conjugated peanut agglutinin (PNA) (cat. &#x23;RL1072, Vector laboratories, Burlingame, CA, United&#x20;States). Secondary antibodies (Alexa Fluor 488 and Alexa Fluor 594) and DAPI (cat. &#x23;D8417, Sigma, St Louis, MO, United&#x20;States, 1:2,000 dilution) were also used in the experiments. Confocal microscopy was used to image eye sections (LSM800, Carl Zeiss, Jena, Germany).</p>
</sec>
<sec id="s2-5">
<title>RNA Isolation and RT-PCR</title>
<p>TRIzol (Invitrogen, Austin, TX, United&#x20;States) was used to extract total RNA from the retinas of female <italic>Asrgl1</italic> KO mice and female normal controls, according to the manufacturer&#x2019;s protocol. cDNA was made as previously described. An Eppendorf Mastercycler personal PCR equipment (Eppendorf, Germany) was used to amplify <italic>Asrgl1</italic> genotyping products, which were then analyzed on a 1.5% agarose gel electrophoresis. Using the SYBR PCR Master Mix kit (Applied Biosystems, Foster City, CA) and the 7500 Fast Real-Time PCR detection machine, equal amounts of cDNA from the retinas of <italic>Asrgl1</italic> KO mice and normal controls were submitted to PCR. Specific primers used in our study were listed in <xref ref-type="sec" rid="s11">Supplementary Data&#x20;S1</xref>.</p>
</sec>
<sec id="s2-6">
<title>RNA-Seq and Differential Expression Analysis</title>
<p>RNA was isolated from the retinas of female <italic>Asrgl1</italic> KO mice and female normal controls, and the integrity of the RNA was determined using the Bioanalyzer 2100 system&#x2019;s RNA Nano 6000 Assay Kit (Agilent Technologies, CA, United&#x20;States). The library was then produced and tested for transcriptome sequencing using the Agilent Bioanalyzer 2100 instrument. The index-coded samples were clustered using the TruSeq PE Cluster Kit v3-cBot-HS (Illumina) on a cBot Cluster Generation System according to the manufacturer&#x2019;s instructions. The library preparations were sequenced on an Illumina Novaseq device after cluster creation, yielding 150-bp paired-end reads. Raw data (raw readings) in fastq format were processed using in-house perl scripts, resulting in clean, high-quality data. The level of gene expression was measured after reads were mapped to the reference genome. All of the downstream analyses were based on clean, high-quality data. Prior to differential gene expression analysis, the read counts for each sequenced library were modified by one scaling normalization factor using the edgeR tool package. The edgeR R package was used to perform differential expression analysis of two situations. The <italic>P</italic> values were adjusted using the Benjamini and Hochberg method. The criterion for significant differential expression was set at 0.05 corrected <italic>P</italic>-value and log2 fold change. The raw data have been uploaded to the Genome Sequence Archive (<ext-link ext-link-type="uri" xlink:href="https://ngdc.cncb.ac.cn/gsa/browse/CRA005193">https://ngdc.cncb.ac.cn/gsa/browse/CRA005193</ext-link>), and the assigned accession number was CRA005193.</p>
</sec>
<sec id="s2-7">
<title>Functional Analysis, Canonical Pathway Analysis, and Generation of Networks</title>
<p>Top biological functions as well as canonical pathways associated with DEGs generated from the RNA-seq between the <italic>Asrgl1</italic> KO retina and normal controls were identified by Ingenuity pathway analysis (IPA) (Qiagen). Fisher&#x2019;s exact test was used to determine the likelihood of any biological function or canonical pathway being explained only by chance. Algorithmically, molecular interaction networks are created based on the connectivity of the molecules. Fisher&#x2019;s exact test was used to determine network scores, which corresponded to &#x2212;log 10 (<italic>p</italic> value).</p>
</sec>
<sec id="s2-8">
<title>Statistical Analysis</title>
<p>Statistical significance was established using Prism 7.0 software and the Student&#x2019;s <italic>t</italic>-test or one-way ANOVA (GraphPad Software, La Jolla, CA, United&#x20;States). The data are presented as the mean SEM unless otherwise noted in the text and figure legends. The ERG datasets in <xref ref-type="fig" rid="F2">Figure&#x20;2</xref> and the ONL thickness measurement dataset in <xref ref-type="fig" rid="F3">Figure&#x20;3</xref> were subjected to ANOVA tests. The number of animals used in each experiment is indicated by <italic>n</italic>. In the figure legends, the total number of animals used in each experiment is also listed. The following <italic>p</italic> values are indicated by asterisks in the figures: &#x2a;&#x2264;0.05, &#x2a;&#x2a;&#x2264;0.01, and &#x2a;&#x2a;&#x2a;&#x2264;0.001.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>ElectroretinogramERG) examinations of <italic>Asrgl1</italic> KO mice. <bold>(A1&#x2013;A4)</bold> Asrgl1 KO mice at 8&#xa0;months of age exhibited a reduced ERG scotopic response. Reduced amplitude peaks were observed for both the <italic>a</italic>-wave and the <italic>b</italic>-wave at light intensities of 0.3, 3.0, and 20.0&#xa0;cds/m<sup>2</sup> in <italic>Asrgl1</italic> KO mice; two-tailed Student&#x2019;s <italic>t</italic>-test was used. &#x2217;&#x2217;<italic>p</italic>&#xa0;&#x3c;&#xa0;0.01; &#x2217;&#x2217;&#x2217;<italic>p</italic>&#xa0;&#x3c;&#xa0;0.001. <bold>(B1&#x2013;B3)</bold> Compared with WT mice, 8-month-old KO mice exhibited a reduced photopic response at 20.0&#xa0;cds/m<sup>2</sup>; sample size <italic>n</italic>&#xa0;&#x3d;&#xa0;4. A two-tailed Student&#x2019;s <italic>t</italic>-test was used. &#x2217;&#x2217;<italic>p</italic>&#xa0;&#x3c;&#xa0;0.01; &#x2217;&#x2217;&#x2217;<italic>p</italic>&#xa0;&#x3c;&#xa0;0.001.</p>
</caption>
<graphic xlink:href="fcell-09-783547-g002.tif"/>
</fig>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Degeneration of the outer retina in <italic>Asrgl1</italic> KO mice. <bold>(A1,B1,C1)</bold> Hematoxylin and eosin (H&#x26;E) staining of paraffin sections of the <italic>Asrgl1</italic> KO and corresponding control retinas at the ages of 9, 12, and 15&#xa0;months. Scale bar: 25&#xa0;&#x3bc;m. <bold>(A2,B2,C2)</bold> Quantification analysis of the outer nuclei layer (ONL) thickness of the KO (<italic>n</italic>&#xa0;&#x3d;&#xa0;6) and WT (<italic>n</italic>&#xa0;&#x3d;&#xa0;6) retinas from mice at 9, 12, and 15&#xa0;months old. <bold>(A3,B3,C3)</bold> Quantification analysis of the inner nuclei layer (INL) thickness of the KO (<italic>n</italic>&#xa0;&#x3d;&#xa0;6) and WT (<italic>n</italic>&#xa0;&#x3d;&#xa0;6) retinas from mice at 9, 12, and 15&#xa0;months old. <bold>(A4,B4,C4)</bold> Quantification analysis of the outer segment (OS) plus inner segment (IS) thickness of the KO (<italic>n</italic>&#xa0;&#x3d;&#xa0;6) and WT (<italic>n</italic>&#xa0;&#x3d;&#xa0;6) retinas from mice at 9, 12, and 15&#xa0;months old. The <italic>Asrgl1</italic> KO mouse retinas showed a drastically gradual degeneration of the photoreceptor cells at 15&#xa0;months&#x20;old.</p>
</caption>
<graphic xlink:href="fcell-09-783547-g003.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec id="s3-1">
<title>Generation of <italic>Asrgl1</italic> Knockout Mice</title>
<p>ASRGL1 is widely expressed in all human tissues studied, with the highest levels of expression in the brain, female tissues including the uterine cervix and fallopian tube, and male tissues like the testis (<xref ref-type="bibr" rid="B12">Edqvist et&#x20;al., 2015</xref>). To investigate the functions of <italic>AsrgL1 in&#x20;vivo</italic>, <italic>Asrgl1</italic> KO were generated using CRISPR/Cas9 technology. The target sites were selected as exon 3 and exon 4 (<xref ref-type="fig" rid="F1">Figure&#x20;1A</xref>). Genotyping analysis using PCR primers flanking the deletion site revealed the successful generation of <italic>Asrgl1</italic> knockout mice (<xref ref-type="sec" rid="s11">Supplementary Figure S1</xref>). To validate the genomic <italic>Asrgl1</italic> ablation, mouse DNA samples were subjected to Sanger sequencing analysis, and results showed genomic deletion of 1,388&#xa0;bp in <italic>Asrgl1</italic> KO mice (<xref ref-type="fig" rid="F1">Figure&#x20;1B</xref>). Both Sanger sequencing and electrophoresis analysis of cDNA product from <italic>Asrgl1</italic> KO retinas revealed a 301-bp deletion of exon 3 and exon 4 in <italic>Asrgl1</italic> KO (<xref ref-type="fig" rid="F1">Figure&#x20;1C&#x2013;E</xref>). All the above data showed the successful generation of <italic>Asrgl1</italic> KO by CRISPR/Cas9 technology.</p>
</sec>
<sec id="s3-2">
<title>
<italic>Asrgl1</italic> Knockout Mice Exhibited Impaired Visual Function</title>
<p>ERG examination was first performed to test the <italic>in vivo</italic> function of <italic>Asrgl1</italic> in the retina. In three 6-month-old <italic>Asrgl1</italic> KO mice and littermate controls, no abnormal ERG response was observed (data not shown). However, all <italic>Asrgl1</italic> KO mice exhibited reduced scotopic and photopic responses at 8&#xa0;months of age. The mean <italic>a</italic>-&#x20;and <italic>b</italic>-wave amplitudes of <italic>Asrgl1</italic> KO were reduced by approximately 15% and 30%, respectively, in scotopic response tests (<xref ref-type="fig" rid="F2">Figure&#x20;2A1&#x2013;A4</xref>), which indicated altered rod cell function. When compared to WT mice, <italic>Asrgl1</italic> KO had a somewhat flat wave under light-adapted conditions, showing that cone cell function was also impaired in <italic>Asrgl1</italic> KO (<xref ref-type="fig" rid="F2">Figure&#x20;2B1&#x2013;B3</xref>). Although, by H&#x26;E staining, the retinas from <italic>Asrgl1</italic> KO mice revealed no difference in the retinal ONL thickness at 6&#xa0;months of age (<xref ref-type="sec" rid="s11">Supplementary Figure S2</xref>), the thickness of the ONL started to decrease around 9&#xa0;months of age (<xref ref-type="fig" rid="F3">Figure&#x20;3A1, A2</xref>) and gradually intensified at 12&#xa0;months (<xref ref-type="fig" rid="F3">Figure&#x20;3B1, B2</xref>) and 15&#xa0;months of age (<xref ref-type="fig" rid="F3">Figure&#x20;3C1, C2</xref>). The photoreceptor layer including the inner segment and outer segment decreased around 9&#xa0;months (<xref ref-type="fig" rid="F3">Figure&#x20;3A1, A4</xref>) and intensified at 12&#xa0;months (<xref ref-type="fig" rid="F3">Figure&#x20;3B1, B4</xref>) and 15&#xa0;months of age (<xref ref-type="fig" rid="F3">Figure&#x20;3C1, C4</xref>). There was no obvious change in the inner nuclei layer (INL) of <italic>Asrgl1</italic> KO at 9&#xa0;months of age (<xref ref-type="fig" rid="F3">Figure&#x20;3A1, A3</xref>), and the thickness of the INL in <italic>Asrgl1</italic> KO was slightly decreased at 15&#xa0;months of age (<xref ref-type="fig" rid="F3">Figure&#x20;3C1,&#x20;C3</xref>).</p>
</sec>
<sec id="s3-3">
<title>Loss of <italic>Asrgl1</italic> Leads to Degeneration and Apoptosis of Photoreceptor Cells</title>
<p>To investigate the pathological changes underlying the <italic>Asrgl1</italic> knockout mice&#x2019;s retinal degeneration phenotype, immunostaining was performed with retinal cryosections in <italic>Asrgl1</italic> KO and WT mice. There were no changes in rhodopsin and M-opsin expression in <italic>Asrgl1</italic> KO at 8&#xa0;months of age (<xref ref-type="sec" rid="s11">Supplementary Figure S3A, B</xref>). However, decreased rhodopsin protein was observed in the photoreceptor of 12- and 15-month-old <italic>Asrgl1</italic> KO mice, respectively (<xref ref-type="fig" rid="F4">Figure&#x20;4A, C</xref>), compared to WT mice, which indicated a shortened outer segment of 12- and 15-month-old <italic>Asrgl1</italic> KO mice. Rhodopsin is a key outer segment protein that is required for adequate vision, and its manufacture and transit are tightly regulated (<xref ref-type="bibr" rid="B28">Palczewski, 2006</xref>). Decreased rhodopsin is cytotoxic and leads to rod death. Decreased Na-K ATP staining in 15-month-old <italic>Asrgl1</italic> KO mice indicated shortened inner segment. M-opsin, a cone cell marker, and PNA (which binds to the sheaths of the cone matrix in all three types of cones) were also used to stain retinal sections. The number of cone cells was reduced in 12-month-old <italic>Asrgl1</italic> KO mice and drastically decreased in 15-month-old <italic>Asrgl1</italic> KO mice (<xref ref-type="fig" rid="F4">Figure&#x20;4B,D</xref>). A TUNEL assay was utilized to determine whether the retinal degeneration was caused by apoptosis. There were no changes in TUNEL-positive cells in 8-month-old <italic>Asrgl1</italic> KO mice (<xref ref-type="sec" rid="s11">Supplementary Figure S3C</xref>). TUNEL-positive cells were substantially more abundant at 15&#xa0;months of age in <italic>Asrgl1</italic> KO retinas than in WT retinas (<xref ref-type="fig" rid="F4">Figure&#x20;4E,F</xref>), and TUNEL-labeled nuclei were mostly found in the ONL, indicating continuous photoreceptor cell death in Asrgl1 KO retinas.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Immunofluorescence staining analysis of the <italic>Asrgl1</italic> KO retinas. <bold>(A,C)</bold> Retinal cryosections from 12- and 15-month-old mice (<italic>n</italic>&#xa0;&#x3d;&#xa0;6) were labelled with rod-specific markers rhodopsin (outer segment) and Na-K ATPase (inner segment). <bold>(B,D)</bold> M-opsin and peanut agglutinin (PNA) was used as the cone markers in 12- and 15-month-old mice (<italic>n</italic>&#xa0;&#x3d;&#xa0;6). DAPI was used to counterstain the nuclei; scale bars: 25&#xa0;&#x3bc;m. The data shown are representative of three independent tests. At least three slides of each retina were stained. <bold>(E)</bold> TUNEL assays in 15-month-old WT and KO mice revealed increased apoptosis. The magnified square indicated TUNEL-positive cells in the retinas. This experiment was performed three times. Sample size <italic>n</italic>&#xa0;&#x3d;&#xa0;6. <bold>(F)</bold> Quantification of TUNEL-positive cells in WT and KO retinas; sample size <italic>n</italic>&#xa0;&#x3d;&#xa0;6; &#x2217;&#x2217;&#x2217;<italic>p</italic>&#xa0;&#x3c;&#xa0;0.001. Statistical significance was determined by a two-tailed unpaired <italic>t</italic>-test.</p>
</caption>
<graphic xlink:href="fcell-09-783547-g004.tif"/>
</fig>
</sec>
<sec id="s3-4">
<title>Differentially Expressed Genes in the Retinas Between <italic>Asrgl1</italic> KO and Normal Controls</title>
<p>To investigate the transcriptional effect of <italic>Asrgl1</italic> ablation, mouse retinal tissues from 8-month-old <italic>Asrgl1</italic> KO (<italic>n</italic>&#xa0;&#x3d;&#xa0;3) and WT mice (<italic>n</italic>&#xa0;&#x3d;&#xa0;4) were subjected to RNA-seq analysis. There were 149 DEGs identified in <italic>Asrgl1</italic> mice (<xref ref-type="sec" rid="s11">Supplementary Table S2</xref>), among which 89 were upregulated (<italic>p</italic>&#xa0;&#x2264;&#xa0;0.01 and log2 ratio &#x2265;1) and 60 (<italic>p</italic>&#xa0;&#x2264;&#xa0;0.01 and log2 ratio &#x2264;&#x2212;1) were downregulated. Volcano plots of differentially expressed genes are shown in <xref ref-type="fig" rid="F5">Figure&#x20;5A</xref>. IPA was used to identify numerous highly enriched biological processes related with DEGs in order to investigate the biological functions enriched in DEGs (<xref ref-type="table" rid="T1">Table&#x20;1</xref>). Gastrointestinal disease (<italic>p</italic> value: 4.79E&#x2212;02 to 2.61E&#x2212;05, 13 genes assigned), organismal injury and abnormalities (<italic>p</italic> value: 4.94E&#x2212;02 to 2.61E&#x2212;05, 31 genes assigned), and cancer (<italic>p</italic> value: 4.79E&#x2212;02 to 3.23E&#x2212;04, 18 genes assigned) were discovered as the top three highly enriched terms in the perspective of diseases and disorders. Cellular development (<italic>p</italic> value: 4.16E&#x2212;02 to 3.14E&#x2212;05, seven genes assigned), cell morphology (<italic>p</italic> value: 4.79E&#x2212;02 to 1.07E&#x2212;03, six genes assigned), and cell death and survival (<italic>p</italic> value: 4.94E&#x2212;02 to 1.22E&#x2212;03, seven genes assigned) were found as the top three highly enriched terms in the perspective of molecular and cellular functions. Digestive system development and function (<italic>p</italic> value: 3.38E&#x2212;02 to 2.61E&#x2212;05, seven genes assigned), organ morphology (<italic>p</italic> value: 4.48E&#x2212;02 to 2.61E&#x2212;05, 13 genes assigned), and hematological system development and function (<italic>p</italic> value: 4.60E&#x2212;02 to 3.14E&#x2212;05, seven genes assigned) were shown as the top three enriched terms in the perspective of physiological system development and functions.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Volcano plots of differentially expressed genes (DEGs) and top canonical pathways involved in <italic>Asrgl1</italic> KO mice. <bold>(A)</bold> Volcano plots of DEG profile. The vertical lines correspond to 2.0 FC up and down, and the horizontal line represents &#x2212;log 10 (<italic>P</italic>-value). <bold>(B)</bold> Ingenuity pathway was used to analyze the total significantly differentially expressed genes and identify the canonical pathways involved in <italic>Asrgl1</italic> KO mice. The top five significant pathways identified were displayed (blue bar). The red curve shows the total number of genes in each of these pathways.</p>
</caption>
<graphic xlink:href="fcell-09-783547-g005.tif"/>
</fig>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Functional analysis for the DEGs in the retina between <italic>Asrgl1</italic> knockout mice and normal controls.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Top diseases and bio functions</th>
<th align="center">
<italic>p</italic>-value range</th>
<th align="left">&#x23; of molecules</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td colspan="3" align="left">Diseases and disorders</td>
</tr>
<tr>
<td align="left">&#x2003;Gastrointestinal disease</td>
<td align="center">4.79E&#x2212;02&#x2013;2.61E&#x2212;05</td>
<td align="char" char=".">13</td>
</tr>
<tr>
<td align="left">&#x2003;Organismal injury and abnormalities</td>
<td align="center">4.94E&#x2212;02&#x2013;2.61E&#x2212;05</td>
<td align="char" char=".">31</td>
</tr>
<tr>
<td align="left">&#x2003;Cancer</td>
<td align="center">4.79E&#x2212;02&#x2013;3.23E&#x2212;04</td>
<td align="char" char=".">18</td>
</tr>
<tr>
<td align="left">&#x2003;Dermatological diseases and conditions</td>
<td align="center">4.48E&#x2212;02&#x2013;1.07E&#x2212;03</td>
<td align="char" char=".">8</td>
</tr>
<tr>
<td align="left">&#x2003;Reproductive system disease</td>
<td align="center">3.85E&#x2212;02&#x2013;1.32E&#x2212;03</td>
<td align="char" char=".">8</td>
</tr>
<tr>
<td colspan="3" align="left">Molecular and cellular functions</td>
</tr>
<tr>
<td align="left">&#x2003;Cellular development</td>
<td align="center">4.16E&#x2212;02&#x2013;3.14E&#x2212;05</td>
<td align="char" char=".">7</td>
</tr>
<tr>
<td align="left">&#x2003;Cell morphology</td>
<td align="center">4.79E&#x2212;02&#x2013;1.07E&#x2212;03</td>
<td align="char" char=".">6</td>
</tr>
<tr>
<td align="left">&#x2003;Cell death and survival</td>
<td align="center">4.94E&#x2212;02&#x2013;1.22E&#x2212;03</td>
<td align="char" char=".">7</td>
</tr>
<tr>
<td align="left">&#x2003;Cellular growth and proliferation</td>
<td align="center">4.16E&#x2212;02&#x2013;1.22E&#x2212;03</td>
<td align="char" char=".">5</td>
</tr>
<tr>
<td align="left">&#x2003;Amino acid metabolism</td>
<td align="center">19.76E&#x2212;03&#x2013;3.26E&#x2212;03</td>
<td align="char" char=".">1</td>
</tr>
<tr>
<td colspan="3" align="left">Physiological system development and function</td>
</tr>
<tr>
<td align="left">&#x2003;Digestive system development and function</td>
<td align="center">3.38E&#x2212;02&#x2013;2.61E&#x2212;05</td>
<td align="char" char=".">7</td>
</tr>
<tr>
<td align="left">&#x2003;Organ morphology</td>
<td align="center">4.48E&#x2212;02&#x2013;2.61E&#x2212;05</td>
<td align="char" char=".">13</td>
</tr>
<tr>
<td align="left">&#x2003;Hematological system development and function</td>
<td align="center">4.60E&#x2212;02&#x2013;3.14E&#x2212;05</td>
<td align="char" char=".">7</td>
</tr>
<tr>
<td align="left">&#x2003;Lymphoid tissue structure and development</td>
<td align="center">1.94E&#x2212;02&#x2013;3.14E&#x2212;05</td>
<td align="char" char=".">2</td>
</tr>
<tr>
<td align="left">&#x2003;Hair and skin development and function</td>
<td align="center">4.48E&#x2212;02&#x2013;1.07E&#x2212;03</td>
<td align="char" char=".">3</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="Tfn1">
<label>a</label>
<p>Range of p-values indicate higher-level functions that contained multiple lower-level functions.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3-5">
<title>Glucocorticoid Receptor Signaling Pathway Is Involved in <italic>Asrgl1</italic> Knockout Mice</title>
<p>Canonical pathway analysis could inform the key metabolism and signaling pathways in which the DEGs may be involved. The main metabolism and signaling pathways in which DEGs may be engaged could be informed <italic>via</italic> canonical pathway analysis. In this study, canonical molecular pathways enriched by DEGs were explored by bioinformation analysis of IPA software. <xref ref-type="fig" rid="F5">Figure&#x20;5B</xref> shows the top five canonical pathways in the retina of <italic>Asrgl1</italic> KO mice that are significantly associated with DEGs. The glucocorticoid receptor signaling (<italic>p</italic> value&#xa0;&#x3d;&#xa0;9.36E&#x2212;06), intrinsic prothrombin activation pathway (<italic>p</italic> value&#xa0;&#x3d;&#xa0;2.78E&#x2212;04), and xenobiotic metabolism AHR signaling pathway (<italic>p</italic> value&#xa0;&#x3d;&#xa0;2.04E&#x2212;03) were the top three major pathways altered in retinal tissues in <italic>Asrgl1</italic> KO mouse. The molecules that were changed in the glucocorticoid receptor signaling were IL1&#x3b2;, KRT5, KRT7, KRT13, KRT14, KRT15, KRT19, KRT80, and KRT6B. Our results firstly suggested an association of <italic>Asrgl1</italic> with GR signaling in the pathological process of retinitis pigmentosa.</p>
</sec>
<sec id="s3-6">
<title>Influenced Interaction Network by Ablation of <italic>Asrgl1</italic> in Mouse Retina</title>
<p>The molecular interaction networks were then created and ranked based on the connectivity of the detected DEGs. The network of &#x201c;Cell Morphology, Embryonic Development&#x201d; (score &#x3d; 49) (<xref ref-type="fig" rid="F6">Figure&#x20;6</xref>) was the most enriched network alerted in retinal tissues of <italic>Asrgl1</italic> KO mice. Notably, several genes including NFE2L2, IL-4, Foxp3, and Fos were the core &#x201c;nodes&#x201d; with the most connections in the network. To validate the expression levels of the main altered genes in glucocorticoid receptor signaling pathway and network of &#x201c;Cell Morphology, Embryonic Development,&#x201d; real-time PCR was performed. As <xref ref-type="fig" rid="F7">Figure&#x20;7</xref> shows, the expression of KRT5, KRT7, KRT13, KRT14, KRT15, KRT19, and KRT80 in glucocorticoid receptor signaling pathway all increased in <italic>Asrgl1</italic> knockout mice compared to the normal controls. Interestingly, only the expression of Foxp3 was decreased among the selected &#x201c;central node&#x201d; genes, namely, NFE2L2, IL-4, Foxp3, and Fos. As Foxp3 is a transcriptional regulator that is required for regulatory T-cell development and inhibitory activity (Treg) (<xref ref-type="bibr" rid="B22">Li et&#x20;al., 2015</xref>), its function in <italic>Arsgl1</italic>-related RP needs to be explored further in follow-up studies.</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>Molecular interaction networks. The most significant biological network of &#x201c;Cell Morphology, Embryonic Development&#x201d; was generated. Upregulated mRNAs are indicated in red, while downregulated mRNAs are in green. Solid lines represent the direct function, while the dotted lines represent the indirect function.</p>
</caption>
<graphic xlink:href="fcell-09-783547-g006.tif"/>
</fig>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption>
<p>Transcriptional validation of the differentially expressed genes in <italic>Asrgl1</italic> KO mice. The expression of Krt5, Krt7, Krt13, Krt14, Krt15, Krt19, and Krt80 in glucocorticoid receptor signaling pathway and the &#x201c;central node&#x201d; genes, NFE2L2, IL-4, Foxp3, and Fos, in the interaction network between WT and <italic>Asrgl1</italic> KO mice (<italic>n</italic>&#xa0;&#x3d;&#xa0;6) was validated by real-time PCR. A two-tailed Student&#x2019;s <italic>t</italic>-test was used; &#x2217;&#x2217;<italic>p</italic>&#xa0;&#x3c;&#xa0;0.01; &#x2217;&#x2217;&#x2217;<italic>p</italic>&#xa0;&#x3c;&#xa0;0.001. Data were from an average of four samples per group. Each test was repeated at least three&#x20;times.</p>
</caption>
<graphic xlink:href="fcell-09-783547-g007.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>RP is the leading cause of inherited blindness in the developed world. Although more than 90 genes have been found associated to RP, some of the gene functions remain unknown (<xref ref-type="bibr" rid="B11">Dias et&#x20;al., 2018</xref>). There are numerous RP animal models available, which have contributed to a better understanding of the disease&#x2019;s pathogenesis and the development of therapeutic strategies targeted at curing or delaying the hereditary illness (<xref ref-type="bibr" rid="B29">Petersen-Jones, 1998</xref>). In this study, we generated a novel <italic>Asrgl1</italic> knockout mouse model to investigate the <italic>in vivo</italic> roles of <italic>ASRGL1</italic>, a new RP gene reported in&#x20;2016.</p>
<p>We found <italic>Asrgl1</italic> ablation led to an attenuated ERG response around 8&#xa0;months. The thickness of the ONL started to decrease at around 9&#xa0;months in <italic>Asrgl1</italic> KO mice and gradually intensified at 12 and 15&#xa0;months. Thinner IS and OS as well as the diminished expression of functional markers in the rod and cone were revealed by immunostaining in <italic>Asrgl1</italic> KO mice. Although the patients exhibited an early-onset retinal dystrophy, late-onset retinal dystrophy was observed in <italic>Asrgl1</italic> KO mice. It is not uncommon for the phenotypes of people with <italic>Asrgl1</italic> mutations and those of knockout mice to differ. One example is the difference between patients with CRB1 mutations and retinal degeneration-8 (rd8) mice phenotypes. CRB1 mutations led to retinitis pigmentosa 12, LCA8, or childhood- and juvenile-onset cone&#x2013;rod dystrophy (<xref ref-type="bibr" rid="B10">den Hollander et&#x20;al., 2004</xref>; <xref ref-type="bibr" rid="B5">Bujakowska et&#x20;al., 2012</xref>). The majority of the patients exhibited severe vision loss. However, <xref ref-type="bibr" rid="B24">Mehalow et&#x20;al. (2003)</xref> described a new mouse model, rd8, with a single-base loss in the Crb1 gene in mice. rd8 mutation resulted in a frameshift and premature stop codon. The truncated protein lost the transmembrane and cytoplasmic domains of CRB1. However, rd8 homozygous mutant mice only exhibited mild retinal degeneration. Photoreceptor degeneration was observed only within spotted regions of the retina. Furthermore, the severity of retinal pathology is influenced by genetic backgrounds (<xref ref-type="bibr" rid="B1">Aleman et&#x20;al., 2011</xref>; <xref ref-type="bibr" rid="B23">Luhmann et&#x20;al., 2015</xref>). Thus, our <italic>Asrgl1</italic> knockout mouse model showed a late-onset photoreceptor degeneration phenotype, which is valuable to investigate the pathogenesis in <italic>ASRGL1</italic>-related RP and further assess the <italic>in vivo</italic> function of <italic>Asrgl1</italic> in the retina.</p>
<p>The 308-amino-acid ASRGL1 protein is activated by autocleavage at amino acid 168, forming an alpha- and beta-chain that can dimerize into a heterodimer (<xref ref-type="bibr" rid="B6">Cantor et&#x20;al., 2009</xref>; <xref ref-type="bibr" rid="B21">Li et&#x20;al., 2012</xref>). In some brain regions, the ASRGL1 enzyme is involved in the synthesis of L-aspartate, which can operate as an excitatory neurotransmitter. In endometrioid endometrial carcinoma, loss of <italic>ASRGL1</italic> expression was an independent biomarker for disease-specific survival, and combined <italic>ASRGL1</italic> and p53 could be used as an independent predictor of survival (<xref ref-type="bibr" rid="B12">Edqvist et&#x20;al., 2015</xref>; <xref ref-type="bibr" rid="B17">Huvila et&#x20;al., 2018</xref>). <italic>Asrgl1</italic> was reported to be trafficked by neural stem/progenitor cell (NSC)-derived extracellular vesicles (EVs) and thus enables NSC EVs as independent metabolic units with asparaginase activity (<xref ref-type="bibr" rid="B19">Iraci et&#x20;al., 2017</xref>). <xref ref-type="bibr" rid="B4">Biswas et&#x20;al. (2016</xref>) showed that the p.G178R mutation in <italic>ASRGL1</italic> impaired the autocatalytic processing of ASRGL1 and resulted in the function loss of <italic>ASRGL1</italic>, which caused early-onset recessive retinal degeneration in a five-generation pedigree. Although the authors observed retinal abnormalities and loss of cone photoreceptors in a zebrafish model, the <italic>in vivo</italic> function of <italic>ASRGL1</italic> in mammalian animals remains unknown. In our study, we firstly observed the photoreceptor degeneration in <italic>Asrgl1</italic> knockout mouse models as well as the transcriptional molecular changes in the <italic>Asrgl1</italic> knockout mouse retina.</p>
<p>Deletion of genomic fragments in <italic>Asrgl1</italic> knockout mice was performed by CRISPR/Cas9 technology. Several available antibodies against ASRGL1 were subjected to immunoblotting and immunostaining analysis. Unfortunately, none of them worked well. Since <italic>Asrgl1</italic> is consist of seven exons and encodes a 326-amino-acid protein in <italic>Mus musculus</italic>, the deletion of a 301-bp fragment spanning exon 3 and exon 4 in <italic>Asrgl1</italic> knockout mice most likely led to generation of shortened proteins lacking majority of the downstream domains after exon 2 and resulted in impaired formation of heterodimer comprising an alpha- and beta-chain by autocleavage.</p>
<p>To further reveal the molecular mechanism of <italic>ASRGL1</italic> in mouse retinas, we explored differentially expressed genes, pathways, and interaction network in <italic>Asrgl1</italic> knockout mouse retinas by transcriptional analysis. Our results suggested an important role of glucocorticoid receptor signaling in the physiology of <italic>Asrgl1</italic>-related retinal degeneration. Although glucocorticoid receptor (GR) has been found in various cell types of the eye, including the retina, little is known yet about the mechanism of glucocorticoid signaling in distinct layers of the eye (<xref ref-type="bibr" rid="B20">Kadmiel and Cidlowski, 2013</xref>; <xref ref-type="bibr" rid="B14">Gallina et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B32">Sulaiman et&#x20;al., 2018</xref>). As GR signaling is commonly associated with anti-inflammatory responses, GR agonists are widely used to treat inflammatory diseases of the eye. Further investigation is warranted to explore how <italic>ASRG1L</italic> influence the glucocorticoid receptor signaling pathway and its role in the pathological process of RP. Interestingly, glucocorticoids have been reported to suppress the expression of a subset of the keratin family genes K5-K14, K6-K16, and K17 (<xref ref-type="bibr" rid="B30">Radoja et&#x20;al., 2000</xref>). However, in the present study, several genes in the keratin gene family, such as Krt5, Krt7, Krt13, Krt14, Krt15, Krt19, and Krt80, were found to have increased transcriptional expression in the <italic>Asrgl1</italic> knockout mice. The keratin gene family consists the highest number of members in humans with 54 distinct functional genes (<xref ref-type="bibr" rid="B25">Moll et&#x20;al., 2008</xref>). The functions of several keratins in the eye have been reported. Krt8/keratin 8 was shown to protect against degeneration of retinal pigment epithelium under oxidative stress (<xref ref-type="bibr" rid="B2">Baek et&#x20;al., 2017</xref>), and KRT3 and KRT12 gene mutations associated with Meesmann corneal dystrophy (<xref ref-type="bibr" rid="B7">Chen et&#x20;al., 2015</xref>). However, the function of keratin family genes in the retinas still needs to be further investigated. Several molecular interaction networks were generated using the identified DEGs. In the most enriched network, &#x201c;Cell Morphology, Embryonic Development,&#x201d; NFE2L2, IL-4, Foxp3, and Fos were the network&#x2019;s central &#x201c;nodes&#x201d; with the greatest number of connections, which indicated the important roles of these molecules in the <italic>Asrgl1</italic> knockout retina. NFE2L2 (NRF2) is a transcription factor involved in the oxidative stress response, which has been linked to several ocular diseases (<xref ref-type="bibr" rid="B18">Ildefonso et&#x20;al., 2016</xref>; <xref ref-type="bibr" rid="B26">Naguib et&#x20;al., 2021</xref>). An anti-inflammatory cytokine, IL-4, has been reported to inhibit the proliferation of retinal cells (<xref ref-type="bibr" rid="B31">Silva et&#x20;al., 2008</xref>). Foxp3 is a transcriptional regulator that is required for regulatory T-cell development and inhibitory activity (Treg). Foxp3&#x2b; Tregs can be recruited to the retina to repair abnormal angiogenesis (<xref ref-type="bibr" rid="B9">Deliyanti et&#x20;al., 2017</xref>). C-fos has been linked to cell death and regeneration in retinal ganglion cells (<xref ref-type="bibr" rid="B27">Oshitari et&#x20;al., 2002</xref>). Through c-Fos, inflammatory signals from photoreceptors influenced pathological retinal angiogenesis (<xref ref-type="bibr" rid="B33">Sun et&#x20;al., 2017</xref>). Except the most enriched network &#x201c;Cell Morphology, Embryonic Development,&#x201d; several other interaction networks with lower scores were identified (not shown). Although, we revealed the transcriptional regulation of glucocorticoid receptor signaling pathway and several molecules in <italic>Asrgl1</italic> KO mice, the intrinsic mechanism will be further explored in our future&#x20;work.</p>
<p>In conclusion, our study firstly explored the function of <italic>Asrgl1</italic> using a novel knockout mouse model and confirm its role in the pathological process of RP. Studies utilizing mouse models have been proven important not only in recapitulation of the disease phenotype in humans but also in improving our understanding of disease mechanisms, and this knockout model is valuable for further development of translational therapeutic approaches.</p>
</sec>
</body>
<back>
<sec id="s5">
<title>Data Availability Statement</title>
<p>The data presented in the study are deposited in the Genome Sequence Archive (<ext-link ext-link-type="uri" xlink:href="https://ngdc.cncb.ac.cn/gsa/browse/CRA005193">https://ngdc.cncb.ac.cn/gsa/browse/CRA005193</ext-link>), accession number was CRA005193.</p>
</sec>
<sec id="s6">
<title>Ethics Statement</title>
<p>The animal study was reviewed and approved by the Animal Care and Use Committee of the Sichuan Provincial People&#x2019;s Hospital.</p>
</sec>
<sec id="s7">
<title>Author Contributions</title>
<p>XZ and YZ designed the study. WT, WL, XJ, HY, ZJ, XL, DJ, KS, and YY performed the experiments and plotted the data. YZ and WT validated the data and drafted the manuscript. YZ and XZ reviewed and edited the manuscript. XZ funded the experiments for the study. All authors contributed to the article and approved the submitted version.</p>
</sec>
<sec id="s8">
<title>Funding</title>
<p>This work was supported by the National Natural Science Foundation of China (81970825, 81970841, and 81221003), the Department of Science and Technology of Sichuan Province (22JCQN0028 and 2021YFS0386), the CAMS Innovation Fund for Medical Sciences (2019-12M-5-032), the Department of Chengdu Science and Technology (nos. 2018-YF05-01080-SN and 2021-YF05-01316-SN), and the National University Basic funding (ZYGX2021J026).</p>
</sec>
<sec sec-type="COI-statement" id="s9">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s10">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors, and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ack>
<p>The authors would like to thank Chengdu LiLai Biotechnology Co., Ltd for providing technical assistance with histology analysis.</p>
</ack>
<sec id="s11">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fcell.2021.783547/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fcell.2021.783547/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="Table2.xlsx" id="SM1" mimetype="application/xlsx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Image3.tif" id="SM2" mimetype="application/tif" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Image2.tif" id="SM3" mimetype="application/tif" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Image1.tif" id="SM4" mimetype="application/tif" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table1.XLSX" id="SM5" mimetype="application/XLSX" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aleman</surname>
<given-names>T. S.</given-names>
</name>
<name>
<surname>Cideciyan</surname>
<given-names>A. V.</given-names>
</name>
<name>
<surname>Aguirre</surname>
<given-names>G. K.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>W. C.</given-names>
</name>
<name>
<surname>Mullins</surname>
<given-names>C. L.</given-names>
</name>
<name>
<surname>Roman</surname>
<given-names>A. J.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>HumanCRB1-Associated Retinal Degeneration: Comparison with Therd8&#x20;Crb1-Mutant Mouse Model</article-title>. <source>Invest. Ophthalmol. Vis. Sci.</source> <volume>52</volume>, <fpage>6898</fpage>&#x2013;<lpage>6910</lpage>. <pub-id pub-id-type="doi">10.1167/iovs.11-7701</pub-id> </citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baek</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Yoon</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Baek</surname>
<given-names>Y. M.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Autophagy and KRT8/keratin 8 Protect Degeneration of Retinal Pigment Epithelium under Oxidative Stress</article-title>. <source>Autophagy</source> <volume>13</volume>, <fpage>248</fpage>&#x2013;<lpage>263</lpage>. <pub-id pub-id-type="doi">10.1080/15548627.2016.1256932</pub-id> </citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhatti</surname>
<given-names>M. T.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Retinitis Pigmentosa, Pigmentary Retinopathies, and Neurologic Diseases</article-title>. <source>Curr. Neurol. Neurosci. Rep.</source> <volume>6</volume>, <fpage>403</fpage>&#x2013;<lpage>413</lpage>. <pub-id pub-id-type="doi">10.1007/s11910-996-0021-z</pub-id> </citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Biswas</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Chavali</surname>
<given-names>V. R.</given-names>
</name>
<name>
<surname>Agnello</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Stone</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Chakarova</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Duncan</surname>
<given-names>J.&#x20;L.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>A Missense Mutation in ASRGL1 Is Involved in Causing Autosomal Recessive Retinal Degeneration</article-title>. <source>Hum. Mol. Genet.</source> <volume>25</volume>, <fpage>2483</fpage>&#x2013;<lpage>2497</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddw113</pub-id> </citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bujakowska</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Audo</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Mohand-Sa&#xef;d</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lancelot</surname>
<given-names>M.-E.</given-names>
</name>
<name>
<surname>Antonio</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Germain</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>CRB1 Mutations in Inherited Retinal Dystrophies</article-title>. <source>Hum. Mutat.</source> <volume>33</volume>, <fpage>306</fpage>&#x2013;<lpage>315</lpage>. <pub-id pub-id-type="doi">10.1002/humu.21653</pub-id> </citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cantor</surname>
<given-names>J.&#x20;R.</given-names>
</name>
<name>
<surname>Stone</surname>
<given-names>E. M.</given-names>
</name>
<name>
<surname>Chantranupong</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Georgiou</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>The Human Asparaginase-like Protein 1 hASRGL1 Is an Ntn Hydrolase with &#x3b2;-Aspartyl Peptidase Activity</article-title>. <source>Biochemistry</source> <volume>48</volume>, <fpage>11026</fpage>&#x2013;<lpage>11031</lpage>. <pub-id pub-id-type="doi">10.1021/bi901397h</pub-id> </citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>J.&#x20;L.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>B. R.</given-names>
</name>
<name>
<surname>Gee</surname>
<given-names>K. M.</given-names>
</name>
<name>
<surname>Gee</surname>
<given-names>J.&#x20;A.</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>D. W.</given-names>
</name>
<name>
<surname>Frausto</surname>
<given-names>R. F.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Identification of Presumed Pathogenic KRT3 and KRT12 Gene Mutations Associated with Meesmann Corneal Dystrophy</article-title>. <source>Mol. Vis.</source> <volume>21</volume>, <fpage>1378</fpage>&#x2013;<lpage>1386</lpage>. </citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Daiger</surname>
<given-names>S. P.</given-names>
</name>
<name>
<surname>Sullivan</surname>
<given-names>L. S.</given-names>
</name>
<name>
<surname>Bowne</surname>
<given-names>S. J.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Genes and Mutations Causing Retinitis Pigmentosa</article-title>. <source>Clin. Genet.</source> <volume>84</volume>, <fpage>132</fpage>&#x2013;<lpage>141</lpage>. <pub-id pub-id-type="doi">10.1111/cge.12203</pub-id> </citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deliyanti</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Talia</surname>
<given-names>D. M.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Maxwell</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Agrotis</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Jerome</surname>
<given-names>J.&#x20;R.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Foxp3&#x2b; Tregs Are Recruited to the Retina to Repair Pathological Angiogenesis</article-title>. <source>Nat. Commun.</source> <volume>8</volume>, <fpage>748</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-017-00751-w</pub-id> </citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>den Hollander</surname>
<given-names>A. I.</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>van der Velde-Visser</surname>
<given-names>S. D.</given-names>
</name>
<name>
<surname>Zonneveld</surname>
<given-names>M. N.</given-names>
</name>
<name>
<surname>Pierrottet</surname>
<given-names>C. O.</given-names>
</name>
<name>
<surname>Koenekoop</surname>
<given-names>R. K.</given-names>
</name>
<etal/>
</person-group> (<year>2004</year>). <article-title>CRB1 Mutation Spectrum in Inherited Retinal Dystrophies</article-title>. <source>Hum. Mutat.</source> <volume>24</volume>, <fpage>355</fpage>&#x2013;<lpage>369</lpage>. <pub-id pub-id-type="doi">10.1002/humu.20093</pub-id> </citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dias</surname>
<given-names>M. F.</given-names>
</name>
<name>
<surname>Joo</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kemp</surname>
<given-names>J.&#x20;A.</given-names>
</name>
<name>
<surname>Fialho</surname>
<given-names>S. L.</given-names>
</name>
<name>
<surname>Cunha</surname>
<given-names>A. D. S.</given-names>
<suffix>Jr.</suffix>
</name>
<name>
<surname>Woo</surname>
<given-names>S. J.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Molecular Genetics and Emerging Therapies for Retinitis Pigmentosa: Basic Research and Clinical Perspectives</article-title>. <source>Prog. Retin. Eye Res.</source> <volume>63</volume>, <fpage>107</fpage>&#x2013;<lpage>131</lpage>. <pub-id pub-id-type="doi">10.1016/j.preteyeres.2017.10.004</pub-id> </citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Edqvist</surname>
<given-names>P.-H. D.</given-names>
</name>
<name>
<surname>Huvila</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Forsstr&#xf6;m</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Talve</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Carp&#xe9;n</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Salvesen</surname>
<given-names>H. B.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Loss of ASRGL1 Expression Is an Independent Biomarker for Disease-specific Survival in Endometrioid Endometrial Carcinoma</article-title>. <source>Gynecol. Oncol.</source> <volume>137</volume>, <fpage>529</fpage>&#x2013;<lpage>537</lpage>. <pub-id pub-id-type="doi">10.1016/j.ygyno.2015.03.055</pub-id> </citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferrari</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Di Iorio</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Barbaro</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Ponzin</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Sorrentino</surname>
<given-names>F. S.</given-names>
</name>
<name>
<surname>Parmeggiani</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Retinitis Pigmentosa: Genes and Disease Mechanisms</article-title>. <source>Curr. Genomics</source> <volume>12</volume>, <fpage>238</fpage>&#x2013;<lpage>249</lpage>. <pub-id pub-id-type="doi">10.2174/138920211795860107</pub-id> </citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gallina</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Zelinka</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Fischer</surname>
<given-names>A. J.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Glucocorticoid Receptors in the Retina, M&#xfc;ller Glia and the Formation of M&#xfc;ller Glia-Derived Progenitors</article-title>. <source>Development</source> <volume>141</volume>, <fpage>3340</fpage>&#x2013;<lpage>3351</lpage>. <pub-id pub-id-type="doi">10.1242/dev.109835</pub-id> </citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hartong</surname>
<given-names>D. T.</given-names>
</name>
<name>
<surname>Berson</surname>
<given-names>E. L.</given-names>
</name>
<name>
<surname>Dryja</surname>
<given-names>T. P.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Retinitis Pigmentosa</article-title>. <source>The Lancet</source> <volume>368</volume>, <fpage>1795</fpage>&#x2013;<lpage>1809</lpage>. <pub-id pub-id-type="doi">10.1016/s0140-6736(06)69740-7</pub-id> </citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>X.-F.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>K.-C.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Pang</surname>
<given-names>C.-P.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Genotype-phenotype Correlation and Mutation Spectrum in a Large Cohort of Patients with Inherited Retinal Dystrophy Revealed by Next-Generation Sequencing</article-title>. <source>Genet. Med.</source> <volume>17</volume>, <fpage>271</fpage>&#x2013;<lpage>278</lpage>. <pub-id pub-id-type="doi">10.1038/gim.2014.138</pub-id> </citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huvila</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Laajala</surname>
<given-names>T. D.</given-names>
</name>
<name>
<surname>Edqvist</surname>
<given-names>P.-H.</given-names>
</name>
<name>
<surname>Mardinoglu</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Talve</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Pont&#xe9;n</surname>
<given-names>F.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Combined ASRGL1 and P53 Immunohistochemistry as an Independent Predictor of Survival in Endometrioid Endometrial Carcinoma</article-title>. <source>Gynecol. Oncol.</source> <volume>149</volume>, <fpage>173</fpage>&#x2013;<lpage>180</lpage>. <pub-id pub-id-type="doi">10.1016/j.ygyno.2018.02.016</pub-id> </citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ildefonso</surname>
<given-names>C. J.</given-names>
</name>
<name>
<surname>Jaime</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>E. E.</given-names>
</name>
<name>
<surname>Iwata</surname>
<given-names>R. L.</given-names>
</name>
<name>
<surname>Ahmed</surname>
<given-names>C. M.</given-names>
</name>
<name>
<surname>Massengill</surname>
<given-names>M. T.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Targeting the Nrf2 Signaling Pathway in the Retina with a Gene-Delivered Secretable and Cell-Penetrating Peptide</article-title>. <source>Invest. Ophthalmol. Vis. Sci.</source> <volume>57</volume>, <fpage>372</fpage>&#x2013;<lpage>386</lpage>. <pub-id pub-id-type="doi">10.1167/iovs.15-17703</pub-id> </citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iraci</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Gaude</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Leonardi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Costa</surname>
<given-names>A. S. H.</given-names>
</name>
<name>
<surname>Cossetti</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Peruzzotti-Jametti</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Extracellular Vesicles Are Independent Metabolic Units with Asparaginase Activity</article-title>. <source>Nat. Chem. Biol.</source> <volume>13</volume>, <fpage>951</fpage>&#x2013;<lpage>955</lpage>. <pub-id pub-id-type="doi">10.1038/nchembio.2422</pub-id> </citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kadmiel</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cidlowski</surname>
<given-names>J.&#x20;A.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Glucocorticoid Receptor Signaling in Health and Disease</article-title>. <source>Trends Pharmacol. Sci.</source> <volume>34</volume>, <fpage>518</fpage>&#x2013;<lpage>530</lpage>. <pub-id pub-id-type="doi">10.1016/j.tips.2013.07.003</pub-id> </citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Cantor</surname>
<given-names>J.&#x20;R.</given-names>
</name>
<name>
<surname>Yogesha</surname>
<given-names>S. D.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Chantranupong</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J.&#x20;Q.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Uncoupling Intramolecular Processing and Substrate Hydrolysis in the N-Terminal Nucleophile Hydrolase hASRGL1 by Circular Permutation</article-title>. <source>ACS Chem. Biol.</source> <volume>7</volume>, <fpage>1840</fpage>&#x2013;<lpage>1847</lpage>. <pub-id pub-id-type="doi">10.1021/cb300232n</pub-id> </citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Tsun</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>FOXP3&#x2b; Regulatory T&#x20;Cells and Their Functional Regulation</article-title>. <source>Cell Mol Immunol</source> <volume>12</volume>, <fpage>558</fpage>&#x2013;<lpage>565</lpage>. <pub-id pub-id-type="doi">10.1038/cmi.2015.10</pub-id> </citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luhmann</surname>
<given-names>U. F. O.</given-names>
</name>
<name>
<surname>Carvalho</surname>
<given-names>L. S.</given-names>
</name>
<name>
<surname>Holthaus</surname>
<given-names>S.-M. k.</given-names>
</name>
<name>
<surname>Cowing</surname>
<given-names>J.&#x20;A.</given-names>
</name>
<name>
<surname>Greenaway</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Chu</surname>
<given-names>C. J.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>The Severity of Retinal Pathology in Homozygous Crb1rd8/rd8 Mice Is Dependent on Additional Genetic Factors</article-title>. <source>Hum. Mol. Genet.</source> <volume>24</volume>, <fpage>128</fpage>&#x2013;<lpage>141</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddu424</pub-id> </citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mehalow</surname>
<given-names>A. K.</given-names>
</name>
<name>
<surname>Kameya</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>R. S.</given-names>
</name>
<name>
<surname>Hawes</surname>
<given-names>N. L.</given-names>
</name>
<name>
<surname>Denegre</surname>
<given-names>J.&#x20;M.</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>J.&#x20;A.</given-names>
</name>
<etal/>
</person-group> (<year>2003</year>). <article-title>CRB1 Is Essential for External Limiting Membrane Integrity and Photoreceptor Morphogenesis in the Mammalian Retina</article-title>. <source>Hum. Mol. Genet.</source> <volume>12</volume>, <fpage>2179</fpage>&#x2013;<lpage>2189</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddg232</pub-id> </citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moll</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Divo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Langbein</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>The Human Keratins: Biology and Pathology</article-title>. <source>Histochem. Cel Biol</source> <volume>129</volume>, <fpage>705</fpage>&#x2013;<lpage>733</lpage>. <pub-id pub-id-type="doi">10.1007/s00418-008-0435-6</pub-id> </citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Naguib</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Backstrom</surname>
<given-names>J.&#x20;R.</given-names>
</name>
<name>
<surname>Gil</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Calkins</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Rex</surname>
<given-names>T. S.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Retinal Oxidative Stress Activates the NRF2/ARE Pathway: An Early Endogenous Protective Response to Ocular Hypertension</article-title>. <source>Redox Biol.</source> <volume>42</volume>, <fpage>101883</fpage>. <pub-id pub-id-type="doi">10.1016/j.redox.2021.101883</pub-id> </citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oshitari</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Dezawa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Okada</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Takano</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Negishi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Horie</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2002</year>). <article-title>The Role of C-Fos in Cell Death and Regeneration of Retinal Ganglion Cells</article-title>. <source>Invest. Ophthalmol. Vis. Sci.</source> <volume>43</volume>, <fpage>2442</fpage>&#x2013;<lpage>2449</lpage>. </citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Palczewski</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>G Protein-Coupled Receptor Rhodopsin</article-title>. <source>Annu. Rev. Biochem.</source> <volume>75</volume>, <fpage>743</fpage>&#x2013;<lpage>767</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.biochem.75.103004.142743</pub-id> </citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Petersen-Jones</surname>
<given-names>S. M.</given-names>
</name>
</person-group> (<year>1998</year>). <article-title>Animal Models of Human Retinal Dystrophies</article-title>. <source>Eye (Lond)</source> <volume>12</volume>, <fpage>566</fpage>&#x2013;<lpage>570</lpage>. <pub-id pub-id-type="doi">10.1038/eye.1998.146</pub-id> </citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Radoja</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Komine</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Jho</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>Blumenberg</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tomic-Canic</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Novel Mechanism of Steroid Action in Skin through Glucocorticoid Receptor Monomers</article-title>. <source>Mol. Cel Biol</source> <volume>20</volume>, <fpage>4328</fpage>&#x2013;<lpage>4339</lpage>. <pub-id pub-id-type="doi">10.1128/mcb.20.12.4328-4339.2000</pub-id> </citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Silva</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Campellocosta</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Linden</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Shollfranco</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Interleukin-4 Blocks Proliferation of Retinal Progenitor Cells and Increases Rod Photoreceptor Differentiation through Distinct Signaling Pathways</article-title>. <source>J.&#x20;Neuroimmunology</source> <volume>196</volume>, <fpage>82</fpage>&#x2013;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1016/j.jneuroim.2008.03.003</pub-id> </citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sulaiman</surname>
<given-names>R. S.</given-names>
</name>
<name>
<surname>Kadmiel</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cidlowski</surname>
<given-names>J.&#x20;A.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Glucocorticoid Receptor Signaling in the Eye</article-title>. <source>Steroids</source> <volume>133</volume>, <fpage>60</fpage>&#x2013;<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1016/j.steroids.2017.11.002</pub-id> </citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C.-H.</given-names>
</name>
<name>
<surname>Gong</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liegl</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Fredrick</surname>
<given-names>T. W.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Inflammatory Signals from Photoreceptor Modulate Pathological Retinal Angiogenesis via C-Fos</article-title>. <source>J.&#x20;Exp. Med.</source> <volume>214</volume>, <fpage>1753</fpage>&#x2013;<lpage>1767</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20161645</pub-id> </citation>
</ref>
</ref-list>
</back>
</article>